Samsara BioCapital »

Vtv Therapeutics Inc Cl A shares owned by Samsara BioCapital

Quarter-by-quarter ownership of Vtv Therapeutics Inc Cl A (VTVT) shares owned by Samsara BioCapital from 13F filings

Historical chart of Samsara BioCapital investment in Vtv Therapeutics Inc Cl A

Tip: Access up to 7 years of quarterly data

All positions including Vtv Therapeutics Inc Cl A held by Samsara BioCapital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vtv Therapeutics Inc Cl A by Samsara BioCapital

Quarter filed Position value Share count Share price at filing
2023-12-31 $470k 41k 11.50

More positions owned by Samsara BioCapital

Scholar Rock Hldg Corp (SRRK)
Rayzebio
Cargo Therapeutics (CRGX)
Mineralys Therapeutics (MLYS)
Arcellx Common Stock (ACLX)
Neurogene (NGNE)
Graphite Bio
Nkarta (NKTX)
Acelyrin (SLRN)
Zymeworks Del (ZYME)
Lyra Therapeutics (LYRA)
Syros Pharmaceuticals Com New (SYRS)
Avadel Pharmaceuticals Sponsored Adr (AVDL)
Hillevax (HLVX)
Abivax Sa Sponsored Ads (ABVX)

View all positions for Samsara BioCapital

Top funds holding Vtv Therapeutics Inc Cl A

Samsara BioCapital
Vanguard Group
Planning Capital Management Corp
Royal Bank of Canada
Focused Wealth Management
Advisor Group Holdings
Parallel Advisors
Wells Fargo & Company
Cornerstone Planning Group
Sunbelt Securities
Central Trust & Investment
Bank of America Corporation
Jpmorgan Chase & Co

View all funds holding Vtv Therapeutics Inc Cl A